10/22/2026
Celiac Drug from First Tracks Reduces Symptoms and Damage in Early Stage Trial! 😄
First Tracks Biotherapeutics has announced positive results from their early-stage clinical trial testing ANB033 for use in celiac disease 🙌
The news marks the third celiac disease clinical trial reporting positive results over the last month or so! 👏
Stay tuned and follow Beyond Celiac for more Research News!🔍
Learn more about this study and how you can help advance research at the links below: 💚
Research News:
https://hubs.li/Q04BP0Tl0
Join a Clinical Trial:
https://hubs.li/Q04BP15_0